Barely Significant
← all excerpts

Comprehensive Analysis Revealed that <i>CDKN2A</i> is a Biomarker for Immune Infiltrates in Multiple Cancers.

Front Cell Dev Biol · 2021 · PMC8733648 · PMID 35004697

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

extremely significantno p-value reported
This analysis revealed that CDKN2A expression was extremely significant in 15 tumors compared with their normal tissue, including KICH (Kidney Chromophobe), BRCA (Breast invasive carcinoma), HNSC (Head and Neck squamous cell carcinoma), CHOL (Cholangiocarcinoma), COAD (Colon adenocarcinoma), KIRC (Kidney renal clear cell carcinoma), PRAD (Prostate adenocarcinoma), KIRP (Kidney renal papillary cell carcinoma), THCA (Thyroid carcinoma), LIHC (Liver hepatocellular carcinoma), STAD (Stomach adenocarcinoma), LUAD (Lung adenocarcinoma), UCEC (Uterine Corpus Endometrial Carcinoma) and READ (Rectum adenocarcinoma).

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.